Ian Laxina, MD
Cardiovascular Disease · Charleston, SCNPI 1265952634
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (44.3%), food and beverage and grants — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Medtronic at 43.7% of the total. 2025 is the largest year on record at $9,634, 5.5 times the $1,742 reported in 2021. Among cardiovascular disease clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 203 payments — averaging $104.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$9K
- Boston Scientific$6K
- Abbott$5K
- Amgen$727
- Pfizer$229
- Astellas Pharma US Inc$198
- plus $447 from 6 others
What the payments were for
- Grants$4,00019%
- Travel & lodging$9,38544%
- Food & beverage$7,18034%
- Education$6253%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 76 | $9,255 |
| Boston Scientific | 33 | $5,604 |
| Abbott | 32 | $4,730 |
| Amgen | 34 | $727 |
| Pfizer | 11 | $229 |
| Astellas Pharma US Inc | 2 | $198 |
| Inari Medical, Inc. | 3 | $177 |
| E.r. Squibb & Sons, L.L.C. | 4 | $84 |
| Biosense Webster, Inc. | 3 | $78 |
| Boehringer Ingelheim | 2 | $51 |
| Angiodynamics, Inc. | 2 | $36 |
| Chiesi USA, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$21,190 in reported general payments places this provider in the 90th percentile of 257 cardiovascular disease providers in South Carolina.
See all cardiovascular disease providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 20 | $24,894 |
| JardianceEmpagliflozin | 11 | $10,798 |
| Ezetimibe | 25 | $1,174 |
| Rosuvastatin Calcium | 49 | $580 |
| Metoprolol Succinate | 31 | $499 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 15 | $290 |
| Spironolactone | 20 | $268 |
| Atorvastatin Calcium | 24 | $242 |
| Losartan Potassium | 14 | $232 |
| Amlodipine Besylate | 28 | $185 |
| Carvedilol | 26 | $137 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $229 | $24,89420 claims |
| Boehringer IngelheimJardiance | $51 | $10,79811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 257 cardiovascular disease providers in South Carolina.
Other cardiovascular disease in Charleston
- Robert BiedermanCharleston$775K
- Priyanka BhattacharyaCharleston$107K
- James SmithCharleston$64K
- Geetha PintoCharleston$51K
- Pamela MorrisCharleston$23K
- William YarbroughCharleston$19K
- Minh TranCharleston$18K
- Troy BuntingCharleston$16K
- Samuel PowellCharleston$10K
- Jeffrey PaulsenCharleston$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.